发明名称 The combination of a serotonin reuptake inhibitor and irindalone
摘要 The present invention relates to the use of compounds and compositions of compounds having serotonin reuptake inhibiting activity and 5-HT 2C antagonistic, partial agonistic or inverse agonistic activity for the for the treatment of depression and other affective disorders. The combined serotonin reuptake inhibiting effect and the 5-HT 2C antagonistic, partial agonistic or inverse agonistic effect may reside within the same chemical compound or in two different chemical compounds.
申请公布号 AU1850801(A) 申请公布日期 2001.06.18
申请号 AU20010018508 申请日期 2000.12.04
申请人 H. LUNDBECK, A/S 发明人 KLAUS PETER BOGESO;THOMAS IVO FRANCISCUS HUBERT CREMERS
分类号 A61K;A61K31/00;A61K31/135;A61K31/137;A61K31/138;A61K31/15;A61K31/343;A61K31/405;A61K31/4439;A61K31/445;A61K31/4525;A61K31/496;A61K31/497;A61K31/513;A61K31/519;A61K31/55;A61K31/551;A61K33/36;A61K45/06;A61P1/14;A61P3/04;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P43/00;G01N33/94 主分类号 A61K
代理机构 代理人
主权项
地址